Zomedica Corp to Present at OTCQB Venture Virtual Investor Conference

Zomedica Corp, a veterinary biopharmaceutical company operating in the health care sector, has announced that its Chief Executive Officer, Larry Heaton, will present at the OTCQB Venture Virtual Investor Conference on August 7th, 2025. The event, hosted by VirtualInvestorConferences.com, is set to take place at 1:30 PM and will be accessible online for individual and institutional investors, as well as advisors and analysts.

Zomedica Corp, listed on the OTC Bulletin Board, focuses on drug discovery and development for pet health, serving North American customers. The company is known for its point-of-care diagnostic and therapeutic products for equine and companion animals.

As of August 4th, 2025, Zomedica’s close price was $0.038, with a 52-week high of $0.162 on August 12th, 2024, and a 52-week low of $0.015 on March 4th, 2025. The company’s market capitalization stands at $51,970,000, and it has a price-to-earnings ratio of -0.363.

The OTCQB Venture Virtual Investor Conference, now in its seventh year, is a leading investor conference series. It provides a platform for company executives to share their vision and answer questions live. The conference is free to attend, with no cost for live presentations or scheduling one-on-one meetings with management. Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates.

The conference agenda, announced on August 4th, 2025, includes presentations from various companies, including Zomedica Corp. The event aims to provide valuable insights into the companies’ operations and future prospects, making it an important occasion for investors interested in the OTC market.

For more information about Zomedica Corp and its offerings, interested parties can visit their website at www.zomedica.com .